3,4-methylenedioxyamphetamine has been researched along with Dwarfism in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Dwarfism: A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clopper, RR | 1 |
| Adelson, JM | 1 |
| Money, J | 1 |
| Capitanio, MA | 1 |
| Kirkpatrick, JA | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Dwarfism
| Article | Year |
|---|---|
Postpubertal psychosexual function in male hypopituitarism without hypogonadotropinism after growth hormone therapy.
Topics: Adolescent; Adult; Dwarfism; Ejaculation; Growth Hormone; Humans; Hypopituitarism; Love; Male; Psych | 1976 |
Widening of the cranial sutures: a roentgen observation during periods of accelerated growth in patients treated for deprivation dwarfism.
Topics: Age Determination by Skeleton; Arm; Body Height; Body Weight; Child; Child Behavior Disorders; Child | 1969 |